Pharmaceutical

AbbVie looks to add an eighth indication for JAK inhibitor Rinvoq

AbbVie is seeking regulatory approval in the US and EU for Rinvoq as a treatment for giant cell arteritis.

Jul 16, 2024 - 04:00
AbbVie looks to add an eighth indication for JAK inhibitor Rinvoq
AbbVie is seeking regulatory approval in the US and EU for Rinvoq as a treatment for giant cell arteritis.
Read the original article

Tags:

Previous Article

Delix plans further trials with neuroplastogen after positive Phase I data

Next Article

Conflict means millions of children are missing vaccinations, UN says

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Minerva hit with FDA rejection for schizophrenia symptom drug

Minerva hit with FDA rejection for schizophrenia sympto...

Feb 28, 2024

AstraZeneca posts 81% rise in FY 2023 profit after tax

AstraZeneca posts 81% rise in FY 2023 profit after tax

Feb 10, 2024

STAT Health News: Abortion ‘companion networks,’ NEJM’s racist past, and other stories you need to read

STAT Health News: Abortion ‘companion networks,’ NEJM’s...

Dec 7, 2023